Whistleblowers : incentives, disincentives, and protection strategies /

• Κύριος συγγραφέας: Lipman, Frederick D.
• Μορφή: Ηλ. βιβλίο
• Γλώσσα: English
• Έκδοση: Hoboken, N.J. : Wiley, [2012]
• Σειρά: Wiley corporate F & A.
• Θέματα: Whistle blowing > United States.; Business ethics > United States.; Whistle blowing > Law and legislation > United States.; Whistle blowing > Case studies.; BUSINESS & ECONOMICS > Business Ethics.; LAW > Administrative Law & Regulatory Practice.; Business ethics.; Whistle blowing.; Whistle blowing > Law and legislation.; Whistleblowing; Unternehmensethik; Recht; United States.; USA; Electronic books.; Case studies.

 "The book will discuss business protection strategies and best practices in dealing with whistleblowers, as well as the GlaxoSmithKline, Pfizer and other high profile whistleblower cases. The book is expected to appeal to Board members, C-Suite executives, corporate compliance personnel, attorneys for whistleblowers and defense attorneys as well as all potential employee whistleblowers. The book emphasizes the disincentives to whistleblowing, and will review the academic studies of whistleblowers with the idea of developing best practices to deal with whistleblowers: Introduction. 1. Dodd-Frank Incentives to Whistleblowers 2. The Remarkable Story of Cheryl Eckard and the $96 Million Bounty 3. The Pfizer Over $100 Million Bounty Collectors 4. Other Statutory Incentives to Whistleblowing 5. Disincentives to Whistleblowers and Academic Studies of Whistleblowers 6. Best Practices in Complying with the U.S. Department of Justice Guidelines 7. Best Practices for CEOs in Dealing with Whistleblowers 8. Best Practices for Conducting Whistleblower Investigations 9. The New SEC Whistleblower Rules 10. Qui Tam Actions and Their Defense "--   Provided by publisher. 

 Front Matter -- Introduction -- The Whistleblowers and the Dodd₆Frank Incentives. The Dramatic Expansion of Whistleblower Awards under Dodd₆Frank -- The Remarkable Story of Cheryl Eckard and the $96 Million Bounty under the False Claims Act -- The Pfizer Whistleblowers who Collected Over $100 Million under the False Claims Act -- Disincentives and Factors Motivating Public Disclosure. Disincentives to Internal Whistleblowers -- Women as Whistleblowers: Factors Motivating Public Whistleblowing -- Organizational Best Practices. Why Should Organizations Adopt a Robust Whistleblower System? -- Establishing a Robust Whistleblower System -- Statutory Incentives and Sec Award Regulations. The False Claims Act: Qui Tam Cases -- IRS Whistleblowers -- Other Statutory Incentives and Protections for Whistleblowers -- A Step₆by₆Step Guide to SEC Whistleblowers Awards under Dodd₆Frank -- Appendix 1: IRS Form 211 -- Appendix 2: SEC Form TCR--Tip, Complaint or Referral -- Appendix 3: SEC Form WB-APP--Application for Award for Original Information Submitted Pursuant to Section 21F of the Securities Exchange Act of 1934 -- Appendix 4: SEC Whistleblower Rules -- About the Author -- Index.